Aditxt, Inc. Equity Method Investment, Quoted Market Value
Aditxt, Inc. (ADTX) had Equity Method Investment, Quoted Market Value of $35.00 million as of 2023-03-31, per its 10-Q filed 2023-11-14.
Discontinued › Notes › Equity Method Investments and Joint Ventures
us-gaap:EquityMethodInvestmentQuotedMarketValue · last filed 2023-11-14
- 2023-03-31: Equity Method Investment, Quoted Market Value $35.00M; Equity Method Investment, Quoted Market Value as first filed $2.50M.
| Period end | Equity Method Investment, Quoted Market Value | Equity Method Investment, Quoted Market Value as first filed |
|---|---|---|
| 2023-03-31 | $35.00M 10-Q · filed 2023-11-14 | $2.50M 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |